K Number
K031524
Device Name
GAMMAMED PLUS 3/24 HDR REMOTE AFTERLOADER
Date Cleared
2003-11-26

(195 days)

Product Code
Regulation Number
892.5700
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The GammaMedplus 3/24 is a remotely controlled afterloading brachytherapy device used to apply a radionuclide source into the body or to the surface of the body for radiation therapy. The system is designed to provide a predetermined dose of radiation to tissue and organs by means of manipulating a radioactive source from a shielded position within in the device into a catheter, applicator, or needle, which has been placed within or on a patient. The remote afterloading device must be contained in a shielded facility during extension of the radioactive source. The GammaMedplus 3/24 may optionally be configured as a transportable device.
Device Description
The GammaMedplus 3/24 is a remote afterloading system used to deliver a radioactive source for use in high-dose rate brachytherapy. The Gammamed 3/24 is loaded with sources no greater than 10 curies. The GammaMedplus 3/24 differs from its predicate device in that it has only five treatment channels. The GammaMedplus 3/24 consists of a remote afterloading device, an optional transportable trolley, and operator console. The GammaMedplus 3/24 remote afterloading device contains a radioactive source, a shielded safe in which to park the source when not in use, motors to drive the source, an indexer to determine the treatment channel for the source, position encoders for the source, electronic control circuit boards, a battery pack for backup power, and a power supply. The radioactive material is sealed inside a stainless steel source capsule. The source capsule is attached to the source cable to form the source assembly. The source cable is also fabricated from stainless steel. The source assembly is housed inside a source tube. The source tube assembly is surrounded by tungsten metal which is used as shielding material. The radiation dose rate at a distance of one meter from the GammaMedplus 3/24 afterloading device when containing a source of the maximum activity is less than 3μGy/h. An electro-mechanical key lock is provided to prevent actuation of the source when the afterloading device is not in use. The source quide tubes attach to the afterloading device by means of a special quick connector. The source may be exposed through a particular channel only if the source guide tube is properly attached to this channel. The applicators to be employed in a particular treatment are connected to the GammaMedplus indexer by way of the source quide tubes. The afterloading device also contains a simulation ("dummy") source assembly. This simulation source assembly is identical to the actual source assembly except that it does not contain radioactive material. The simulation source makes it possible to test the condition and location of the source guide tube and the applicators and their connections before carrying out the actual treatment. The device is equipped with 5 access channels, through which the single iridium192 source can be manipulated. The source exit port can be raised or lowered into a position that is optimal in relation to the particular patient. The position of the exit port of the afterloading device can be varied from 900 millimeters (34 inches) above the floor to 1800 millimeters (51 inches) above the floor. A wide range of flexible and rigid applicators is available for a wide variety of brachytherapy techniques. The afterloading device is equipped with an emergency hand crank to permit the emergency retraction of the source. The hand crank is a "one way" hand crank, which allows only retraction of the source. It is not possible to expose the source using this hand crank. The afterloading device can be installed onto a trolley for transportation. The GammaMed trolley consists of a rectangular chassis with four large casters for easy movement of the equipment. It has a manually operated brake that reliably maintains its position during treatment.
More Information

Not Found

No
The description focuses on the mechanical and electronic control of a radioactive source for brachytherapy, with no mention of AI or ML for tasks like treatment planning, image analysis, or device control.

Yes
The device is described as an afterloading brachytherapy device used to apply a radionuclide source into or onto the body for radiation therapy, providing a predetermined dose of radiation to tissue and organs. This directly indicates a therapeutic function by delivering radiation for treatment.

No

The device is described as a brachytherapy device used to apply a radionuclide source for radiation therapy, not for diagnosis. Its purpose is to deliver a predetermined dose of radiation to tissue and organs.

No

The device description clearly outlines numerous hardware components including a radioactive source, shielded safe, motors, indexer, position encoders, electronic control circuit boards, battery pack, power supply, source capsule, source cable, source tube, tungsten shielding, electro-mechanical key lock, source guide tubes, applicators, simulation source assembly, emergency hand crank, and an optional transportable trolley. This is a complex hardware system with integrated software for control, not a software-only device.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Function: The GammaMedplus 3/24 is a brachytherapy device that applies a radionuclide source into or onto the body for radiation therapy. It directly interacts with the patient's body to deliver treatment.
  • Lack of Sample Analysis: The description does not mention any analysis of biological samples. The device's function is to deliver radiation, not to test or analyze samples.

Therefore, the GammaMedplus 3/24 falls under the category of a therapeutic medical device, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

The GammaMedplus 3/24 is a remotely controlled afterloading brachytherapy device used to apply a radionuclide source into the body or to the surface of the body for radiation therapy. The system is designed to provide a predetermined dose of radiation to tissue and organs by means of manipulating a radioactive source from a shielded position within in the device into a catheter, applicator, or needle, which has been placed within or on a patient. The remote afterloading device must be contained in a shielded facility during extension of the radioactive source. The GammaMedplus 3/24 may optionally be configured as a transportable device.

Product codes

90 JAQ

Device Description

The GammaMedplus 3/24 is a remote afterloading system used to deliver a radioactive source for use in high-dose rate brachytherapy. The Gammamed 3/24 is loaded with sources no greater than 10 curies. The GammaMedplus 3/24 differs from its predicate device in that it has only five treatment channels.

The GammaMedplus 3/24 consists of a remote afterloading device, an optional transportable trolley, and operator console. The GammaMedplus 3/24 remote afterloading device contains a radioactive source, a shielded safe in which to park the source when not in use, motors to drive the source, an indexer to determine the treatment channel for the source, position encoders for the source, electronic control circuit boards, a battery pack for backup power, and a power supply.

The radioactive material is sealed inside a stainless steel source capsule. The source capsule is attached to the source cable to form the source assembly. The source cable is also fabricated from stainless steel. The source assembly is housed inside a source tube. The source tube assembly is surrounded by tungsten metal which is used as shielding material. The radiation dose rate at a distance of one meter from the GammaMedplus 3/24 afterloading device when containing a source of the maximum activity is less than 3μGy/h.

An electro-mechanical key lock is provided to prevent actuation of the source when the afterloading device is not in use.

The source quide tubes attach to the afterloading device by means of a special quick connector. The source may be exposed through a particular channel only if the source guide tube is properly attached to this channel. The applicators to be employed in a particular treatment are connected to the GammaMedplus indexer by way of the source quide tubes.

The afterloading device also contains a simulation ("dummy") source assembly. This simulation source assembly is identical to the actual source assembly except that it does not contain radioactive material. The simulation source makes it possible to test the condition and location of the source guide tube and the applicators and their connections before carrying out the actual treatment. The device is equipped with 5 access channels, through which the single iridium192 source can be manipulated. The source exit port can be raised or lowered into a position that is optimal in relation to the particular patient. The position of the exit port of the afterloading device can be varied from 900 millimeters (34 inches) above the floor to 1800 millimeters (51 inches) above the floor. A wide range of flexible and rigid applicators is available for a wide variety of brachytherapy techniques.

The afterloading device is equipped with an emergency hand crank to permit the emergency retraction of the source. The hand crank is a "one way" hand crank, which allows only retraction of the source. It is not possible to expose the source using this hand crank.

The afterloading device can be installed onto a trolley for transportation. The GammaMed trolley consists of a rectangular chassis with four large casters for easy movement of the equipment. It has a manually operated brake that reliably maintains its position during treatment.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K983436

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.5700 Remote controlled radionuclide applicator system.

(a)
Identification. A remote controlled radionuclide applicator system is an electromechanical or pneumatic device intended to enable an operator to apply, by remote control, a radionuclide source into the body or to the surface of the body for radiation therapy. This generic type of device may include patient and equipment supports, component parts, treatment planning computer programs, and accessories.(b)
Classification. Class II.

0

NOV 26 2003

K031524

113

510(k) Summary

The following information is provided following the format of 21 CFR 807.92 for the GammaMed plus 3/24 High Dose Rate (HDR) Remote Afterloader

1. Submitter:

Varian Medical Systems 3100 Hansen Way M/S E-110 Palo Alto, CA 94304 Contact Name: Vy Tran Phone: (650) 424-5731 (650) 842-5040 Fax: Email: vy.tran@varian.com Date: September 22, 2003

2. Device Name:

GammaMed plus 3/24 High Dose Rate (HDR) Remote Afterloader System, Applicator, Radionuclide, Remote-Controlled Classification Name: GammaMed plus 3/24 HDR Remote afterloader Common/Usual Name: GammaMed plus 3/24 HDR Remote afterloader Proprietary Name:

3. Equivalent Device:

GammaMed plus HDR Remote Afterloader, K983436

4. Device Description:

The GammaMedplus 3/24 is a remote afterloading system used to deliver a radioactive source for use in high-dose rate brachytherapy. The Gammamed 3/24 is loaded with sources no greater than 10 curies. The GammaMedplus 3/24 differs from its predicate device in that it has only five treatment channels.

The GammaMedplus 3/24 consists of a remote afterloading device, an optional transportable trolley, and operator console. The GammaMedplus 3/24 remote afterloading device contains a radioactive source, a shielded safe in which to park the source when not in use, motors to drive the source, an indexer to determine the treatment channel for the source, position encoders for the source, electronic control circuit boards, a battery pack for backup power, and a power supply.

The radioactive material is sealed inside a stainless steel source capsule. The source capsule is attached to the source cable to form the source assembly. The source cable is also fabricated from stainless steel. The source assembly is housed inside a source tube. The source tube assembly is surrounded by tungsten metal which is used as shielding material. The radiation dose rate at a distance of one meter from the GammaMedplus 3/24 afterloading device when containing a source of the maximum activity is less than 3μGy/h.

1

An electro-mechanical key lock is provided to prevent actuation of the source when the afterloading device is not in use.

The source quide tubes attach to the afterloading device by means of a special quick connector. The source may be exposed through a particular channel only if the source guide tube is properly attached to this channel. The applicators to be employed in a particular treatment are connected to the GammaMedplus indexer by way of the source quide tubes.

The afterloading device also contains a simulation ("dummy") source assembly. This simulation source assembly is identical to the actual source assembly except that it does not contain radioactive material. The simulation source makes it possible to test the condition and location of the source guide tube and the applicators and their connections before carrying out the actual treatment. The device is equipped with 5 access channels, through which the single iridium192 source can be manipulated. The source exit port can be raised or lowered into a position that is optimal in relation to the particular patient. The position of the exit port of the afterloading device can be varied from 900 millimeters (34 inches) above the floor to 1800 millimeters (51 inches) above the floor. A wide range of flexible and rigid applicators is available for a wide variety of brachytherapy techniques.

The afterloading device is equipped with an emergency hand crank to permit the emergency retraction of the source. The hand crank is a "one way" hand crank, which allows only retraction of the source. It is not possible to expose the source using this hand crank.

The afterloading device can be installed onto a trolley for transportation. The GammaMed trolley consists of a rectangular chassis with four large casters for easy movement of the equipment. It has a manually operated brake that reliably maintains its position during treatment.

    1. Statement of Intended Use:
      The GammaMedplus 3/24 is a remotely controlled afterloading brachytherapy device used to apply a radionuclide source into the body or to the surface of the body for radiation therapy. The GammaMedplus 3/24 may optionally be configured as a transportable device.
    1. Comparison to substantially equivalent devices:
Features / Products
DeviceGAMMAMED plusGAMMAMED plus 3/24
FDA clearanceK983436Pending
Base Area57.5 cm x 51 cm57.5 cm x 51 cm
Height105cm-145cm105cm-145cm
Adjustable height position measured
in the center of the indexer90cm-130cm90cm-130cm
Weight130kg130kg
Transportable(USDOT-7A; Type A)YesYes
Power Supply115 V
60 Hz115V
60 Hz
MobileYesYes
HDRYesYes
Number of Channels245
Features / ProductsGAMMAMED plusGAMMAMED plus 3/24
Features / ProductsGAMMAMED plusGAMMAMED plus 3/24
ShieldingTungstenTungsten
Device:
Cont.Maximum shielding activity555 GBq /15 ci555 GBq /15 ci
Maximum treatment activity370 GBq /10 ci370 GBq /10 ci
Maximum exposure rate at 1m.
distance containing the maximum
activity0.3mrm/hr
3 uSv/hr0.3mrem/hr
3 uSv/hr
Dwell positions per each channel6060
Area radiation monitor (integrated
Geiger - Muller)YesYes
Device Control SoftwareGammaWinGammaWin
Maintained treatment data during
power failure (battery powered RAM)YesYes
Simulator sourceYesYes
Verification of channel lengthYesYes
Verification of applicator connectionYesYes
Source positioningDixal to proximalDixal to proximal
Maximum source position error over
treatment length0.35% referencing to
600 mm0.35% referencing to
600 mm
Emergency container for the sourceYesYes
Response to emergency signalAutomatic source
retractionAutomatic source
retraction
Emergency manual retractionYesYes
SourceIsotopeIr-192Ir-192
Maximum activity555 GBq /15 ci555 GBq /15 ci
Maximum treatment activity370 GBq /10 ci370 GBq /10 ci
Capsule dimensions4,52 x 0.9 mm4,52 x 0.9 mm
Active dimensions3,5 x 0.6 mm3,5 x 0.6 mm
Source extension length1300 mm1300 mm
Operator
ConsoleOperating console with Personal with
Personal Computer and PrinterYesYes
Keyswitch controlYesYes
Operating voltage24V from24V from
GammaMedplusGammaMedplus 3/24

2

K031524

3

Image /page/3/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle or bird with three lines representing its body and wings. The bird is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the bird.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

NOV 26 2003

Mr. Vy Tran Corporate Director, Regulatory Affairs Varian Medical Systems, Inc. 3100 Hansen Way PALO ALTO CA 94304-1038

Re: K031524 Trade/Device Name: GammaMed Plus 3/24 HDR Remote Afterloader Regulation Number: 21 CFR 892.5700 Regulation Name: Remote controlled radionuclide applicator system Regulatory Class: II Product Code: 90 JAQ Dated: September 25, 2003 Received: September 29, 2003

Dear Mr. Tran:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

4

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of the letter:

8xx.1xxx(301) 594-4591
876.2xxx, 3xxx, 4xxx, 5xxx(301) 594-4616
884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx(301) 594-4616
892.2xxx, 3xxx, 4xxx, 5xxx(301) 594-4654
Other(301) 594-4692

Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours,

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

K031524 510(k) Number (if known): Device Name: GammaMed Model plus 3/24 HDR Remote afterloader

Indications For Use:

The GammaMedplus 3/24 is a remotely controlled afterloading brachytherapy device used to apply a radionuclide source into the body or to the surface of the body for radiation therapy. The system is designed to provide a predetermined dose of radiation to tissue and organs by means of manipulating a radioactive source from a shielded position within in the device into a catheter, applicator, or needle, which has been placed within or on a patient. The remote afterloading device must be contained in a shielded facility during extension of the radioactive source. The GammaMedplus 3/24 may optionally be configured as a transportable device.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Optional Format 3-10-98)

David R. Syrem

(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number __

Prescription Use